GlassScriptPhysician profile
Jamie O Armbruster
NPI 1699939538
$6,887.43
in general payments reported to CMS, 2019-2025
44 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $161 · 2021: $586 · 2022: $1,173 · 2023: $1,185 · 2024: $1,393 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,001 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,000.52 |
| Education | $158.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,576.74 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Astrazeneca Pharmaceuticals LP | $686.50 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $550.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $482.75 | 2019-2024 | Prolia, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $319.80 | 2022-2025 | |
| Astellas Pharma US INC | $295.56 | 2019-2025 | Veozah |
| Pfizer INC. | $293.89 | 2022-2025 | |
| Aimmune Therapeutics, INC. | $235.77 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $215.84 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $196.15 | 2021-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $192.11 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $173.18 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.75 | 2019-2025 | |
| Ironwood Pharmaceuticals, INC | $162.96 | 2019-2022 | |
| Lilly USA, LLC | $148.47 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Armbruster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.